1. Home
  2. FELE vs ACAD Comparison

FELE vs ACAD Comparison

Compare FELE & ACAD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • FELE
  • ACAD
  • Stock Information
  • Founded
  • FELE 1944
  • ACAD 1993
  • Country
  • FELE United States
  • ACAD United States
  • Employees
  • FELE N/A
  • ACAD N/A
  • Industry
  • FELE Metal Fabrications
  • ACAD Biotechnology: Pharmaceutical Preparations
  • Sector
  • FELE Consumer Discretionary
  • ACAD Health Care
  • Exchange
  • FELE Nasdaq
  • ACAD Nasdaq
  • Market Cap
  • FELE 4.4B
  • ACAD 4.3B
  • IPO Year
  • FELE N/A
  • ACAD 2004
  • Fundamental
  • Price
  • FELE $94.80
  • ACAD $23.96
  • Analyst Decision
  • FELE Hold
  • ACAD Buy
  • Analyst Count
  • FELE 1
  • ACAD 21
  • Target Price
  • FELE $107.00
  • ACAD $29.30
  • AVG Volume (30 Days)
  • FELE 188.1K
  • ACAD 1.9M
  • Earning Date
  • FELE 10-28-2025
  • ACAD 11-05-2025
  • Dividend Yield
  • FELE 1.12%
  • ACAD N/A
  • EPS Growth
  • FELE N/A
  • ACAD 615.00
  • EPS
  • FELE 3.86
  • ACAD 1.33
  • Revenue
  • FELE $2,059,864,000.00
  • ACAD $1,018,885,000.00
  • Revenue This Year
  • FELE $6.91
  • ACAD $14.01
  • Revenue Next Year
  • FELE $5.37
  • ACAD $11.72
  • P/E Ratio
  • FELE $24.51
  • ACAD $17.98
  • Revenue Growth
  • FELE 2.20
  • ACAD 14.41
  • 52 Week Low
  • FELE $78.87
  • ACAD $13.40
  • 52 Week High
  • FELE $111.94
  • ACAD $26.65
  • Technical
  • Relative Strength Index (RSI)
  • FELE 46.29
  • ACAD 44.42
  • Support Level
  • FELE $91.81
  • ACAD $23.34
  • Resistance Level
  • FELE $96.99
  • ACAD $24.87
  • Average True Range (ATR)
  • FELE 2.01
  • ACAD 0.80
  • MACD
  • FELE -0.53
  • ACAD -0.28
  • Stochastic Oscillator
  • FELE 36.51
  • ACAD 18.73

About FELE Franklin Electric Co. Inc.

Franklin Electric Co Inc designs, manufactures, and distributes water and fuel pumping systems, composed of submersible motors, pumps, electronic controls, water treatment systems, and related parts and equipment. It has three segments; The Water Systems segment designs, manufactures and sells motors, pumps, drives, electronic controls, monitoring devices, and related parts and equipment for use in groundwater, water transfer, and wastewater, The Energy Systems segment designs, manufactures and sells pumps, pipe, sumps, fittings, vapor recovery components, electronic controls, monitoring devices, and related parts and equipment for use in fueling system applications and the Distribution segment sells and provides presale support and specifications to the installing contractors.

About ACAD ACADIA Pharmaceuticals Inc.

Acadia Pharmaceuticals Inc is a biopharmaceutical company focused on the development and commercialization of medicines that address unmet medical needs in central nervous system (CNS) disorders and rare diseases. It has two core franchises in neuroscience and neuro-rare diseases. The neuroscience franchise is anchored by its commercial product NUPLAZID (pimavanserin), which is used for the treatment of hallucinations and delusions associated with Parkinson's Disease Psychosis (PDP). The neuro-rare disease franchise is anchored by the commercial product DAYBUE, which is used for the treatment of Rett syndrome. In addition, the company has various product candidates under development in different stages, including ACP-204, ACP-101, ACP-211, ACP-711, ACP-2591, etc.

Share on Social Networks: